AGMB compared with RSVR: revenue, margins and what each company keeps, and the suppliers and customers both name

AGMBAgomab Therapeutics NV

Mkt capRevenueRevenue

RSVRReservoir Media, Inc.

Mkt capRevenueRevenue

Compare

AGMBAgomab Therapeutics NV

RSVRReservoir Media, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AGMB

No earnings history for AGMB.

RSVR

0 of 3at or beyond implied

Reportimpliedrealized× implied

Aug 4 '26—▼−1.08%—

Q1 FY26±13.7%▼−2.40%×0.18

Q3 FY26±5.9%▲+3.74%×0.63

Nov 4 '25±6.6%▲+0.41%×0.06

= impliedAGMB realized, solidRSVR realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

AGMBAgomab Therapeutics NV

7.14▼−10.14%· post 7.15

Mkt cap$255.9MRevenue—Revenue—

RSVRReservoir Media, Inc.

9.55▼−0.41%· post 9.54

ClosedOct 30 '26

Mkt cap$627.7MRevenue$46MQ3 FY26Revenue$159MFY25

Compare

ClosedOct 30 '26

AGMBAgomab Therapeutics NV

RSVRReservoir Media, Inc.

7.14▼−10.14%post 7.15

Price

9.55▼−0.41%post 9.54

$255.9M

Mkt cap

$627.7M

—

Revenue

$46MQ3 FY26

—

Revenue

$159MFY25

AGMB7.14▼−10.14%vsRSVR9.55▼−0.41%ClosedOct 30 '26